 | • レポートコード：D0GIR-02748 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、核循環器の世界市場を広く調査・分析し、今後の市場展望をまとめております。核循環器の種類別市場規模（放射線機器、放射線情報システム（RIS）、放射性医薬品）、用途別市場規模（病院、クリニック、学術研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GE Healthcare、3mensio Medical Imaging、Fujifilm Medical、Shimadzu、Medtronic、Siemens Healthcare、UltraSPECT、Philips Healthcare、Astellas Pharma、Bracco Diagnostics ・地域別グローバル市場分析 2015年-2020年 ・核循環器の北米市場（アメリカ、カナダ、メキシコ） ・核循環器のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・核循環器のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・核循環器の南米市場（ブラジル、アルゼンチン） ・核循環器の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：放射線機器、放射線情報システム（RIS）、放射性医薬品 ・用途別分析：病院、クリニック、学術研究機関、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Nuclear Cardiology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nuclear Cardiology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nuclear Cardiology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nuclear Cardiology market has been segmented into:
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
By Application, Nuclear Cardiology has been segmented into:
Hospitals
Clinics
Academic and Research Institutes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Cardiology market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Cardiology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Cardiology market.
The report offers in-depth assessment of the growth and other aspects of the Nuclear Cardiology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nuclear Cardiology Market Share Analysis
Nuclear Cardiology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Cardiology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Cardiology sales, revenue and market share for each player covered in this report.
The major players covered in Nuclear Cardiology are:
GE Healthcare
3mensio Medical Imaging
Fujifilm Medical
Shimadzu
Medtronic
Siemens Healthcare
UltraSPECT
Philips Healthcare
Astellas Pharma
Bracco Diagnostics
Table of Contents
1 Nuclear Cardiology Market Overview
1.1 Product Overview and Scope of Nuclear Cardiology
1.2 Classification of Nuclear Cardiology by Type
1.2.1 Global Nuclear Cardiology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nuclear Cardiology Revenue Market Share by Type in 2019
1.2.3 Radiology Devices
1.2.4 Radiology Information Systems (RIS)
1.2.5 Radiopharmaceuticals
1.3 Global Nuclear Cardiology Market by Application
1.3.1 Overview: Global Nuclear Cardiology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Global Nuclear Cardiology Market by Regions
1.4.1 Global Nuclear Cardiology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nuclear Cardiology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nuclear Cardiology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nuclear Cardiology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nuclear Cardiology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nuclear Cardiology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nuclear Cardiology Status and Prospect (2015-2025)
2 Company Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GE Healthcare SWOT Analysis
2.1.4 GE Healthcare Product and Services
2.1.5 GE Healthcare Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.2 3mensio Medical Imaging
2.2.1 3mensio Medical Imaging Details
2.2.2 3mensio Medical Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 3mensio Medical Imaging SWOT Analysis
2.2.4 3mensio Medical Imaging Product and Services
2.2.5 3mensio Medical Imaging Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fujifilm Medical
2.3.1 Fujifilm Medical Details
2.3.2 Fujifilm Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Fujifilm Medical SWOT Analysis
2.3.4 Fujifilm Medical Product and Services
2.3.5 Fujifilm Medical Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Shimadzu
2.4.1 Shimadzu Details
2.4.2 Shimadzu Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Shimadzu SWOT Analysis
2.4.4 Shimadzu Product and Services
2.4.5 Shimadzu Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Medtronic SWOT Analysis
2.5.4 Medtronic Product and Services
2.5.5 Medtronic Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Siemens Healthcare SWOT Analysis
2.6.4 Siemens Healthcare Product and Services
2.6.5 Siemens Healthcare Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.7 UltraSPECT
2.7.1 UltraSPECT Details
2.7.2 UltraSPECT Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 UltraSPECT SWOT Analysis
2.7.4 UltraSPECT Product and Services
2.7.5 UltraSPECT Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Philips Healthcare
2.8.1 Philips Healthcare Details
2.8.2 Philips Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Philips Healthcare SWOT Analysis
2.8.4 Philips Healthcare Product and Services
2.8.5 Philips Healthcare Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Astellas Pharma
2.9.1 Astellas Pharma Details
2.9.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Astellas Pharma SWOT Analysis
2.9.4 Astellas Pharma Product and Services
2.9.5 Astellas Pharma Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bracco Diagnostics
2.10.1 Bracco Diagnostics Details
2.10.2 Bracco Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bracco Diagnostics SWOT Analysis
2.10.4 Bracco Diagnostics Product and Services
2.10.5 Bracco Diagnostics Nuclear Cardiology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nuclear Cardiology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nuclear Cardiology Players Market Share
3.2.2 Top 10 Nuclear Cardiology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nuclear Cardiology Revenue and Market Share by Regions
4.2 North America Nuclear Cardiology Revenue and Growth Rate (2015-2020)
4.3 Europe Nuclear Cardiology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Cardiology Revenue and Growth Rate (2015-2020)
4.5 South America Nuclear Cardiology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nuclear Cardiology Revenue and Growth Rate (2015-2020)
5 North America Nuclear Cardiology Revenue by Countries
5.1 North America Nuclear Cardiology Revenue by Countries (2015-2020)
5.2 USA Nuclear Cardiology Revenue and Growth Rate (2015-2020)
5.3 Canada Nuclear Cardiology Revenue and Growth Rate (2015-2020)
5.4 Mexico Nuclear Cardiology Revenue and Growth Rate (2015-2020)
6 Europe Nuclear Cardiology Revenue by Countries
6.1 Europe Nuclear Cardiology Revenue by Countries (2015-2020)
6.2 Germany Nuclear Cardiology Revenue and Growth Rate (2015-2020)
6.3 UK Nuclear Cardiology Revenue and Growth Rate (2015-2020)
6.4 France Nuclear Cardiology Revenue and Growth Rate (2015-2020)
6.5 Russia Nuclear Cardiology Revenue and Growth Rate (2015-2020)
6.6 Italy Nuclear Cardiology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nuclear Cardiology Revenue by Countries
7.1 Asia-Pacific Nuclear Cardiology Revenue by Countries (2015-2020)
7.2 China Nuclear Cardiology Revenue and Growth Rate (2015-2020)
7.3 Japan Nuclear Cardiology Revenue and Growth Rate (2015-2020)
7.4 Korea Nuclear Cardiology Revenue and Growth Rate (2015-2020)
7.5 India Nuclear Cardiology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Cardiology Revenue and Growth Rate (2015-2020)
8 South America Nuclear Cardiology Revenue by Countries
8.1 South America Nuclear Cardiology Revenue by Countries (2015-2020)
8.2 Brazil Nuclear Cardiology Revenue and Growth Rate (2015-2020)
8.3 Argentina Nuclear Cardiology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nuclear Cardiology by Countries
9.1 Middle East & Africa Nuclear Cardiology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nuclear Cardiology Revenue and Growth Rate (2015-2020)
9.3 UAE Nuclear Cardiology Revenue and Growth Rate (2015-2020)
9.4 Egypt Nuclear Cardiology Revenue and Growth Rate (2015-2020)
9.5 South Africa Nuclear Cardiology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nuclear Cardiology Revenue and Market Share by Type (2015-2020)
10.2 Global Nuclear Cardiology Market Forecast by Type (2019-2024)
10.3 Radiology Devices Revenue Growth Rate (2015-2025)
10.4 Radiology Information Systems (RIS) Revenue Growth Rate (2015-2025)
10.5 Radiopharmaceuticals Revenue Growth Rate (2015-2025)
11 Global Nuclear Cardiology Market Segment by Application
11.1 Global Nuclear Cardiology Revenue Market Share by Application (2015-2020)
11.2 Nuclear Cardiology Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Academic and Research Institutes Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Nuclear Cardiology Market Size Forecast (2021-2025)
12.1 Global Nuclear Cardiology Market Size Forecast (2021-2025)
12.2 Global Nuclear Cardiology Market Forecast by Regions (2021-2025)
12.3 North America Nuclear Cardiology Revenue Market Forecast (2021-2025)
12.4 Europe Nuclear Cardiology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nuclear Cardiology Revenue Market Forecast (2021-2025)
12.6 South America Nuclear Cardiology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nuclear Cardiology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nuclear Cardiology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Cardiology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Cardiology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nuclear Cardiology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GE Healthcare Corporate Information, Location and Competitors
Table 6. GE Healthcare Nuclear Cardiology Major Business
Table 7. GE Healthcare Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 8. GE Healthcare SWOT Analysis
Table 9. GE Healthcare Nuclear Cardiology Product and Solutions
Table 10. GE Healthcare Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. 3mensio Medical Imaging Corporate Information, Location and Competitors
Table 12. 3mensio Medical Imaging Nuclear Cardiology Major Business
Table 13. 3mensio Medical Imaging Nuclear Cardiology Total Revenue (USD Million) (2018-2019)
Table 14. 3mensio Medical Imaging SWOT Analysis
Table 15. 3mensio Medical Imaging Nuclear Cardiology Product and Solutions
Table 16. 3mensio Medical Imaging Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Fujifilm Medical Corporate Information, Location and Competitors
Table 18. Fujifilm Medical Nuclear Cardiology Major Business
Table 19. Fujifilm Medical Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 20. Fujifilm Medical SWOT Analysis
Table 21. Fujifilm Medical Nuclear Cardiology Product and Solutions
Table 22. Fujifilm Medical Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Shimadzu Corporate Information, Location and Competitors
Table 24. Shimadzu Nuclear Cardiology Major Business
Table 25. Shimadzu Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 26. Shimadzu SWOT Analysis
Table 27. Shimadzu Nuclear Cardiology Product and Solutions
Table 28. Shimadzu Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Medtronic Corporate Information, Location and Competitors
Table 30. Medtronic Nuclear Cardiology Major Business
Table 31. Medtronic Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 32. Medtronic SWOT Analysis
Table 33. Medtronic Nuclear Cardiology Product and Solutions
Table 34. Medtronic Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Siemens Healthcare Corporate Information, Location and Competitors
Table 36. Siemens Healthcare Nuclear Cardiology Major Business
Table 37. Siemens Healthcare Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 38. Siemens Healthcare SWOT Analysis
Table 39. Siemens Healthcare Nuclear Cardiology Product and Solutions
Table 40. Siemens Healthcare Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. UltraSPECT Corporate Information, Location and Competitors
Table 42. UltraSPECT Nuclear Cardiology Major Business
Table 43. UltraSPECT Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 44. UltraSPECT SWOT Analysis
Table 45. UltraSPECT Nuclear Cardiology Product and Solutions
Table 46. UltraSPECT Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Philips Healthcare Corporate Information, Location and Competitors
Table 48. Philips Healthcare Nuclear Cardiology Major Business
Table 49. Philips Healthcare Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 50. Philips Healthcare SWOT Analysis
Table 51. Philips Healthcare Nuclear Cardiology Product and Solutions
Table 52. Philips Healthcare Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Astellas Pharma Corporate Information, Location and Competitors
Table 54. Astellas Pharma Nuclear Cardiology Major Business
Table 55. Astellas Pharma Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 56. Astellas Pharma SWOT Analysis
Table 57. Astellas Pharma Nuclear Cardiology Product and Solutions
Table 58. Astellas Pharma Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bracco Diagnostics Corporate Information, Location and Competitors
Table 60. Bracco Diagnostics Nuclear Cardiology Major Business
Table 61. Bracco Diagnostics Nuclear Cardiology Total Revenue (USD Million) (2017-2018)
Table 62. Bracco Diagnostics SWOT Analysis
Table 63. Bracco Diagnostics Nuclear Cardiology Product and Solutions
Table 64. Bracco Diagnostics Nuclear Cardiology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Nuclear Cardiology Revenue (Million USD) by Players (2015-2020)
Table 66. Global Nuclear Cardiology Revenue Share by Players (2015-2020)
Table 67. Global Nuclear Cardiology Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Nuclear Cardiology Revenue Market Share by Regions (2015-2020)
Table 69. North America Nuclear Cardiology Revenue by Countries (2015-2020)
Table 70. North America Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Table 71. Europe Nuclear Cardiology Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Nuclear Cardiology Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Nuclear Cardiology Revenue by Countries (2015-2020)
Table 74. South America Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Nuclear Cardiology Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Table 77. Global Nuclear Cardiology Revenue (Million USD) by Type (2015-2020)
Table 78. Global Nuclear Cardiology Revenue Share by Type (2015-2020)
Table 79. Global Nuclear Cardiology Revenue Forecast by Type (2021-2025)
Table 80. Global Nuclear Cardiology Revenue by Application (2015-2020)
Table 81. Global Nuclear Cardiology Revenue Share by Application (2015-2020)
Table 82. Global Nuclear Cardiology Revenue Forecast by Application (2021-2025)
Table 83. Global Nuclear Cardiology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nuclear Cardiology Picture
Figure 2. Global Nuclear Cardiology Revenue Market Share by Type in 2019
Figure 3. Radiology Devices Picture
Figure 4. Radiology Information Systems (RIS) Picture
Figure 5. Radiopharmaceuticals Picture
Figure 6. Nuclear Cardiology Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Academic and Research Institutes Picture
Figure 10. Others Picture
Figure 11. Global Nuclear Cardiology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Nuclear Cardiology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Nuclear Cardiology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Nuclear Cardiology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Nuclear Cardiology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Nuclear Cardiology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Nuclear Cardiology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Nuclear Cardiology Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Nuclear Cardiology Revenue Market Share in 2019
Figure 20. Global Top 10 Players Nuclear Cardiology Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Nuclear Cardiology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Nuclear Cardiology Revenue Market Share by Regions (2015-2020)
Figure 24. Global Nuclear Cardiology Revenue Market Share by Regions in 2018
Figure 25. North America Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 26. Europe Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 28. South America Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 30. North America Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Figure 31. North America Nuclear Cardiology Revenue Market Share by Countries in 2019
Figure 32. USA Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 33. Canada Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 35. Europe Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Nuclear Cardiology Revenue Market Share by Countries in 2019
Figure 37. Germany Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 38. UK Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 39. France Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 40. Russia Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 41. Italy Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Nuclear Cardiology Revenue Market Share by Countries in 2019
Figure 44. China Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 45. Japan Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 46. Korea Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 47. India Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 49. South America Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Figure 50. South America Nuclear Cardiology Revenue Market Share by Countries in 2019
Figure 51. Brazil Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Nuclear Cardiology Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Nuclear Cardiology Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 56. UAE Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Nuclear Cardiology Revenue and Growth Rate (2015-2020)
Figure 59. Global Nuclear Cardiology Revenue Share by Type (2015-2020)
Figure 60. Global Nuclear Cardiology Revenue Share by Type in 2019
Figure 61. Global Nuclear Cardiology Market Share Forecast by Type (2021-2025)
Figure 62. Global Radiology Devices Revenue Growth Rate (2015-2020)
Figure 63. Global Radiology Information Systems (RIS) Revenue Growth Rate (2015-2020)
Figure 64. Global Radiopharmaceuticals Revenue Growth Rate (2015-2020)
Figure 65. Global Nuclear Cardiology Revenue Share by Application (2015-2020)
Figure 66. Global Nuclear Cardiology Revenue Share by Application in 2019
Figure 67. Global Nuclear Cardiology Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Academic and Research Institutes Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Nuclear Cardiology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Nuclear Cardiology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Nuclear Cardiology Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Nuclear Cardiology Revenue Market Forecast (2021-2025)
Figure 76. Europe Nuclear Cardiology Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Nuclear Cardiology Revenue Market Forecast (2021-2025)
Figure 78. South America Nuclear Cardiology Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Nuclear Cardiology Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
循環器外科・インターベンショナル循環器系機器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cardiology Surgical and Interventional Cardiology Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …- 原子力蒸気発生器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Steam Generator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nuclear Steam Generat…
- 核磁気共鳴（NMR）分光計の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Magnetic Resonance (NMR) Spectrometer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1011 million by 2025, from USD 886.2 million in 201…
- 統合循環器装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Integrated Cardiology Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Integrated Card…
- 循環器外科・装置・治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cardiology Surgery, Devices and Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cardiol…